Brian R. Mueller, Chief Accounting Officer and 17-year company veteran, named acting CFO Dan Spiegelman steps down as CFO; will assist with transition until September 1, 2020 SAN RAFAEL, Calif., Feb. 3, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced the transition of Executive Vice President and Chief Financial Officer Dan Spiegelman.Over the last seven and a half years, he has played an invaluable role in supporting the company's growth,"  said Jean-Jaques Bienaimé, Chairman and Chief Executive Officer.